1
|
Hughes DC, Hardee JP, Waddell DS, Goodman CA. CORP: Gene delivery into murine skeletal muscle using in vivo electroporation. J Appl Physiol (1985) 2022; 133:41-59. [PMID: 35511722 DOI: 10.1152/japplphysiol.00088.2022] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The strategy of gene delivery into skeletal muscles has provided exciting avenues in identifying new potential therapeutics towards muscular disorders and addressing basic research questions in muscle physiology through overexpression and knockdown studies. In vivo electroporation methodology offers a simple, rapidly effective technique for the delivery of plasmid DNA into post-mitotic skeletal muscle fibers and the ability to easily explore the molecular mechanisms of skeletal muscle plasticity. The purpose of this review is to describe how to robustly electroporate plasmid DNA into different hindlimb muscles of rodent models. Further, key parameters (e.g., voltage, hyaluronidase, plasmid concentration) which contribute to the successful introduction of plasmid DNA into skeletal muscle fibers will be discussed. In addition, details on processing tissue for immunohistochemistry and fiber cross-sectional area (CSA) analysis will be outlined. The overall goal of this review is to provide the basic and necessary information needed for successful implementation of in vivo electroporation of plasmid DNA and thus open new avenues of discovery research in skeletal muscle physiology.
Collapse
Affiliation(s)
- David C Hughes
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, United States
| | - Justin P Hardee
- Centre for Muscle Research (CMR), Department of Anatomy and Physiology, The University of Melbourne, Victoria, Australia
| | - David S Waddell
- Department of Biology, University of North Florida, Jacksonville, FL, United States
| | - Craig A Goodman
- Centre for Muscle Research (CMR), Department of Anatomy and Physiology, The University of Melbourne, Victoria, Australia
| |
Collapse
|
2
|
Maissan P, Mooij EJ, Barberis M. Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review. BIOLOGY 2021; 10:194. [PMID: 33806509 PMCID: PMC7999230 DOI: 10.3390/biology10030194] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 02/20/2021] [Accepted: 02/25/2021] [Indexed: 02/06/2023]
Abstract
Sirtuins are a family of highly conserved NAD+-dependent proteins and this dependency links Sirtuins directly to metabolism. Sirtuins' activity has been shown to extend the lifespan of several organisms and mainly through the post-translational modification of their many target proteins, with deacetylation being the most common modification. The seven mammalian Sirtuins, SIRT1 through SIRT7, have been implicated in regulating physiological responses to metabolism and stress by acting as nutrient sensors, linking environmental and nutrient signals to mammalian metabolic homeostasis. Furthermore, mammalian Sirtuins have been implicated in playing major roles in mammalian pathophysiological conditions such as inflammation, obesity and cancer. Mammalian Sirtuins are expressed heterogeneously among different organs and tissues, and the same holds true for their substrates. Thus, the function of mammalian Sirtuins together with their substrates is expected to vary among tissues. Any therapy depending on Sirtuins could therefore have different local as well as systemic effects. Here, an introduction to processes relevant for the actions of Sirtuins, such as metabolism and cell cycle, will be followed by reasoning on the system-level function of Sirtuins and their substrates in different mammalian tissues. Their involvement in the healthy metabolism and metabolic disorders will be reviewed and critically discussed.
Collapse
Affiliation(s)
- Parcival Maissan
- Synthetic Systems Biology and Nuclear Organization, Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands;
| | - Eva J. Mooij
- Systems Biology, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, Surrey, UK;
- Centre for Mathematical and Computational Biology, CMCB, University of Surrey, Guildford GU2 7XH, Surrey, UK
| | - Matteo Barberis
- Synthetic Systems Biology and Nuclear Organization, Swammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH Amsterdam, The Netherlands;
- Systems Biology, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, Surrey, UK;
- Centre for Mathematical and Computational Biology, CMCB, University of Surrey, Guildford GU2 7XH, Surrey, UK
| |
Collapse
|
3
|
Fritzen AM, Lundsgaard AM, Kiens B. Tuning fatty acid oxidation in skeletal muscle with dietary fat and exercise. Nat Rev Endocrinol 2020; 16:683-696. [PMID: 32963340 DOI: 10.1038/s41574-020-0405-1] [Citation(s) in RCA: 74] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/12/2020] [Indexed: 12/31/2022]
Abstract
Both the consumption of a diet rich in fatty acids and exercise training result in similar adaptations in several skeletal muscle proteins. These adaptations are involved in fatty acid uptake and activation within the myocyte, the mitochondrial import of fatty acids and further metabolism of fatty acids by β-oxidation. Fatty acid availability is repeatedly increased postprandially during the day, particularly during high dietary fat intake and also increases during, and after, aerobic exercise. As such, fatty acids are possible signalling candidates that regulate transcription of target genes encoding proteins involved in muscle lipid metabolism. The mechanism of signalling might be direct or indirect targeting of peroxisome proliferator-activated receptors by fatty acid ligands, by fatty acid-induced NAD+-stimulated activation of sirtuin 1 and/or fatty acid-mediated activation of AMP-activated protein kinase. Lactate might also have a role in lipid metabolic adaptations. Obesity is characterized by impairments in fatty acid oxidation capacity, and individuals with obesity show some rigidity in increasing fatty acid oxidation in response to high fat intake. However, individuals with obesity retain improvements in fatty acid oxidation capacity in response to exercise training, thereby highlighting exercise training as a potential method to improve lipid metabolic flexibility in obesity.
Collapse
Affiliation(s)
- Andreas Mæchel Fritzen
- Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark
| | - Anne-Marie Lundsgaard
- Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark
| | - Bente Kiens
- Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
| |
Collapse
|
4
|
Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism. Cells 2020; 9:cells9081882. [PMID: 32796716 PMCID: PMC7465293 DOI: 10.3390/cells9081882] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Revised: 08/07/2020] [Accepted: 08/07/2020] [Indexed: 12/15/2022] Open
Abstract
Sirtuin1 (Sirt1) has a NAD (+) binding domain and modulates the acetylation status of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α) and Fork Head Box O1 transcription factor (Foxo1) according to the nutritional status. Sirt1 is decreased in obese patients and increased in weight loss. Its decreased expression explains part of the pathomechanisms of the metabolic syndrome, diabetes mellitus type 2 (DT2), cardiovascular diseases and nonalcoholic liver disease. Sirt1 plays an important role in the differentiation of adipocytes and in insulin signaling regulated by Foxo1 and phosphatidylinositol 3′-kinase (PI3K) signaling. Its overexpression attenuates inflammation and macrophage infiltration induced by a high fat diet. Its decreased expression plays a prominent role in the heart, liver and brain of rat as manifestations of fetal programming produced by deficit in vitamin B12 and folate during pregnancy and lactation through imbalanced methylation/acetylation of PGC1α and altered expression and methylation of nuclear receptors. The decreased expression of Sirt1 produced by impaired cellular availability of vitamin B12 results from endoplasmic reticulum stress through subcellular mislocalization of ELAVL1/HuR protein that shuttles Sirt1 mRNA between the nucleus and cytoplasm. Preclinical and clinical studies of Sirt1 agonists have produced contrasted results in the treatment of the metabolic syndrome. A preclinical study has produced promising results in the treatment of inherited disorders of vitamin B12 metabolism.
Collapse
|
5
|
Svensson K, Tahvilian S, Martins VF, Dent JR, Lemanek A, Barooni N, Greyslak K, McCurdy CE, Schenk S. Combined overexpression of SIRT1 and knockout of GCN5 in adult skeletal muscle does not affect glucose homeostasis or exercise performance in mice. Am J Physiol Endocrinol Metab 2020; 318:E145-E151. [PMID: 31794263 PMCID: PMC7052578 DOI: 10.1152/ajpendo.00370.2019] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Sirtuin 1 (SIRT1) and general control of amino acid synthesis 5 (GCN5) regulate mitochondrial biogenesis via opposing modulation of peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) acetylation status and activity. However, the combined contribution of SIRT1 and GCN5 to skeletal muscle metabolism and endurance performance in vivo is unknown. In this study, we investigated the impact of combined skeletal muscle-specific overexpression of SIRT1 and deletion of GCN5 on glucose homeostasis, skeletal muscle mitochondrial biogenesis and function, and metabolic adaptation to endurance exercise training in mice. We generated mice with combined and tamoxifen-inducible skeletal muscle-specific overexpression of SIRT1 and knockout of GCN5 (dTG) and floxed [wild type (WT)] littermates using a Cre-LoxP approach. All mice were treated with tamoxifen at 5-6 wk of age, and 4-7 wk later glucose homeostasis, skeletal muscle contractile function, mitochondrial function, and the effects of 14 days of voluntary wheel running on expression of metabolic proteins and exercise capacity were assessed. There was no difference in oral glucose tolerance, skeletal muscle contractile function, mitochondrial abundance, or maximal respiratory capacity between dTG and WT mice. Additionally, there were no genotype differences in exercise performance and markers of mitochondrial biogenesis after 14 days of voluntary wheel running. These results demonstrate that combined overexpression of SIRT1 and loss of GCN5 in vivo does not promote metabolic remodeling in skeletal muscle of sedentary or exercise-trained mice.
Collapse
Affiliation(s)
- Kristoffer Svensson
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
| | - Shahriar Tahvilian
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
| | - Vitor F Martins
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
- Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California
| | - Jessica R Dent
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
| | - Adrianna Lemanek
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
| | - Neeka Barooni
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
| | - Keenan Greyslak
- Department of Human Physiology, University of Oregon, Eugene, Oregon
| | - Carrie E McCurdy
- Department of Human Physiology, University of Oregon, Eugene, Oregon
| | - Simon Schenk
- Department of Orthopaedic Surgery, University of California, San Diego, La Jolla, California
- Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California
| |
Collapse
|
6
|
Myers MJ, Shepherd DL, Durr AJ, Stanton DS, Mohamed JS, Hollander JM, Alway SE. The role of SIRT1 in skeletal muscle function and repair of older mice. J Cachexia Sarcopenia Muscle 2019; 10:929-949. [PMID: 31197980 PMCID: PMC6711423 DOI: 10.1002/jcsm.12437] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Accepted: 03/21/2019] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Sirtuin 1 (SIRT1) is a NAD+ sensitive deacetylase that has been linked to longevity and has been suggested to confer beneficial effects that counter aging-associated deterioration. Muscle repair is dependent upon satellite cell function, which is reported to be reduced with aging; however, it is not known if this is linked to an aging-suppression of SIRT1. This study tested the hypothesis that Sirtuin 1 (SIRT1) overexpression would increase the extent of muscle repair and muscle function in older mice. METHODS We examined satellite cell dependent repair in tibialis anterior, gastrocnemius, and soleus muscles of 13 young wild-type mice (20-30 weeks) and 49 older (80+ weeks) mice that were controls (n = 13), overexpressed SIRT1 in skeletal muscle (n = 14), and had a skeletal muscle SIRT1 knockout (n = 12) or a satellite cell SIRT1 knockout (n = 10). Acute muscle injury was induced by injection of cardiotoxin (CTX), and phosphate-buffered saline was used as a vector control. Plantarflexor muscle force and fatigue were evaluated before or 21 days after CTX injection. Satellite cell proliferation and mitochondrial function were also evaluated in undamaged muscles. RESULTS Maximal muscle force was significantly lower in control muscles of older satellite cell knockout SIRT1 mice compared to young adult wild-type (YWT) mice (P < 0.001). Mean contraction force at 40 Hz stimulation was significantly greater after recovery from CTX injury in older mice that overexpressed muscle SIRT1 than age-matched SIRT1 knockout mice (P < 0.05). SIRT1 muscle knockout models (P < 0.05) had greater levels of p53 (P < 0.05 MKO, P < 0.001 OE) in CTX-damaged tissues as compared to YWT CTX mice. SIRT1 overexpression with co-expression of p53 was associated with increased fatigue resistance and increased force potentiation during repeated contractions as compared to wild-type or SIRT1 knockout models (P < 0.001). Muscle structure and mitochondrial function were not different between the groups, but proliferation of satellite cells was significantly greater in older mice with SIRT1 muscle knockout (P < 0.05), but not older SIRT1 satellite cell knockout models, in vitro, although this effect was attenuated in vivo after 21 days of recovery. CONCLUSIONS The data suggest skeletal muscle structure, function, and recovery after CTX-induced injury are not significantly influenced by gain or loss of SIRT1 abundance alone in skeletal muscle; however, muscle function is impaired by ablation of SIRT1 in satellite cells. SIRT1 appears to interact with p53 to improve muscle fatigue resistance after repair from muscle injury.
Collapse
Affiliation(s)
- Matthew J. Myers
- Laboratory of Muscle Biology and SarcopeniaWest Virginia University School of MedicineMorgantownUSA
| | - Danielle L. Shepherd
- Division of Exercise Physiology and Center for Cardiovascular and Respiratory SciencesWest Virginia University School of MedicineMorgantownUSA
| | - Andrya J. Durr
- Division of Exercise Physiology and Center for Cardiovascular and Respiratory SciencesWest Virginia University School of MedicineMorgantownUSA
| | - David S. Stanton
- Laboratory of Muscle Biology and SarcopeniaWest Virginia University School of MedicineMorgantownUSA
| | - Junaith S. Mohamed
- Laboratory of Muscle Biology and SarcopeniaWest Virginia University School of MedicineMorgantownUSA
- Laboratory of Nerve and Muscle, Department of Clinical Laboratory Sciences, College of Health ProfessionsUniversity of Tennessee Health Science CenterMemphisUSA
| | - John M. Hollander
- Division of Exercise Physiology and Center for Cardiovascular and Respiratory SciencesWest Virginia University School of MedicineMorgantownUSA
| | - Stephen E. Alway
- Laboratory of Muscle Biology and SarcopeniaWest Virginia University School of MedicineMorgantownUSA
- Laboratory of Muscle Biology and Sarcopenia, Department of Physical Therapy, College of Health ProfessionsUniversity of Tennessee Health Science CenterMemphisUSA
- Department of Physiology, College of MedicineUniversity of Tennessee Health Science CenterMemphisUSA
| |
Collapse
|
7
|
Fritzen AM, Lundsgaard A, Jeppesen JF, Sjøberg KA, Høeg LD, Deleuran HH, Wojtaszewski JFP, Richter EA, Kiens B. Fatty acid type–specific regulation of SIRT1 does not affect insulin sensitivity in human skeletal muscle. FASEB J 2019; 33:5510-5519. [DOI: 10.1096/fj.201801950r] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Andreas Mæchel Fritzen
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Anne‐Marie Lundsgaard
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Jacob Fuglsbjerg Jeppesen
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Kim Anker Sjøberg
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Louise Dalgas Høeg
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Henrik Hall Deleuran
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Jørgen F. P. Wojtaszewski
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Erik A. Richter
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| | - Bente Kiens
- Section of Molecular PhysiologyDepartment of Nutrition, Exercise, and Sports, Faculty of ScienceUniversity of Copenhagen Copenhagen Denmark
| |
Collapse
|
8
|
Small L, Gong H, Yassmin C, Cooney GJ, Brandon AE. Thermoneutral housing does not influence fat mass or glucose homeostasis in C57BL/6 mice. J Endocrinol 2018; 239:313-324. [PMID: 30400016 DOI: 10.1530/joe-18-0279] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Accepted: 09/05/2018] [Indexed: 12/15/2022]
Abstract
One major factor affecting physiology often overlooked when comparing data from animal models and humans is the effect of ambient temperature. The majority of rodent housing is maintained at ~22°C, the thermoneutral temperature for lightly clothed humans. However, mice have a much higher thermoneutral temperature of ~30°C, consequently data collected at 22°C in mice could be influenced by animals being exposed to a chronic cold stress. The aim of this study was to investigate the effect of housing temperature on glucose homeostasis and energy metabolism of mice fed normal chow or a high-fat, obesogenic diet (HFD). Male C57BL/6J(Arc) mice were housed at standard temperature (22°C) or at thermoneutrality (29°C) and fed either chow or a 60% HFD for 13 weeks. The HFD increased fat mass and produced glucose intolerance as expected but this was not exacerbated in mice housed at thermoneutrality. Changing the ambient temperature, however, did alter energy expenditure, food intake, lipid content and glucose metabolism in skeletal muscle, liver and brown adipose tissue. Collectively, these findings demonstrate that mice regulate energy balance at different housing temperatures to maintain whole-body glucose tolerance and adiposity irrespective of the diet. Despite this, metabolic differences in individual tissues were apparent. In conclusion, dietary intervention in mice has a greater impact on adiposity and glucose metabolism than housing temperature although temperature is still a significant factor in regulating metabolic parameters in individual tissues.
Collapse
Affiliation(s)
- Lewin Small
- Diabetes and Metabolism Division, Garvan Institute, Sydney, New South Wales, Australia
| | - Henry Gong
- The University of Sydney, School of Medical Sciences, Charles Perkins Centre, Sydney, New South Wales, Australia
| | - Christian Yassmin
- The University of Sydney, School of Medical Sciences, Charles Perkins Centre, Sydney, New South Wales, Australia
| | - Gregory J Cooney
- Diabetes and Metabolism Division, Garvan Institute, Sydney, New South Wales, Australia
- The University of Sydney, School of Medical Sciences, Charles Perkins Centre, Sydney, New South Wales, Australia
| | - Amanda E Brandon
- Diabetes and Metabolism Division, Garvan Institute, Sydney, New South Wales, Australia
- The University of Sydney, School of Medical Sciences, Charles Perkins Centre, Sydney, New South Wales, Australia
| |
Collapse
|
9
|
Stefanowicz M, Nikołajuk A, Matulewicz N, Karczewska-Kupczewska M. Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity. Endocrine 2018; 60:263-271. [PMID: 29417372 PMCID: PMC5893655 DOI: 10.1007/s12020-018-1544-1] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2017] [Accepted: 01/19/2018] [Indexed: 12/30/2022]
Abstract
PURPOSE Sirtuin 1 may regulate glucose and lipid metabolism. We aimed to assess adipose tissue and skeletal muscle sirtuin 1 expression in relation to insulin sensitivity, the expression of proinflammatory and metabolic genes, and to study the regulation of sirtuin 1 expression by hyperinsulinemia and circulating free fatty acids elevation. METHODS We examined 60 normal-weight, 42 overweight and 15 obese young subjects. The hyperinsulinemic-euglycemic clamp technique was applied throughout to measure insulin sensitivity. In 20 subjects, two 6 h clamps were performed, one of them with concurrent Intralipid/heparin infusion. Biopsies of subcutaneous adipose tissue and skeletal muscle were collected for the measurement of gene and protein expression. RESULTS Obese subjects had lower adipose sirtuin 1 in comparison with normal-weight and overweight participants. Muscle sirtuin 1 did not differ between the groups. Adipose tissue sirtuin 1 was related to insulin sensitivity, adipose tissue SLC2A4. The relationship between adipose tissue sirtuin 1 and insulin sensitivity was still present after controlling for BMI, however, it disappeared after controlling for adipose tissue SLC2A4. Muscle sirtuin 1 was not related to insulin sensitivity. Hyperisulinemia decreased adipose tissue and increased muscle sirtuin 1 expression. Intralipid/heparin infusion negated these effects. CONCLUSIONS Adipose tissue, but not muscle, sirtuin 1 is associated with insulin sensitivity in humans, possibly because of its correlation with adipose tissue SLC2A4 expression. Insulin differentially regulates adipose tissue and skeletal muscle sirtuin 1 expression in the short-term and circulating free fatty acids elevation negates these effects, which may be associated with lipid-induced insulin resistance.
Collapse
Affiliation(s)
- Magdalena Stefanowicz
- Department of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland
| | - Agnieszka Nikołajuk
- Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland
| | - Natalia Matulewicz
- Department of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland
| | - Monika Karczewska-Kupczewska
- Department of Metabolic Diseases, Medical University of Bialystok, Bialystok, Poland.
- Department of Prophylaxis of Metabolic Diseases, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
| |
Collapse
|
10
|
Svensson K, LaBarge SA, Martins VF, Schenk S. Temporal overexpression of SIRT1 in skeletal muscle of adult mice does not improve insulin sensitivity or markers of mitochondrial biogenesis. Acta Physiol (Oxf) 2017; 221:193-203. [PMID: 28544355 DOI: 10.1111/apha.12897] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2017] [Revised: 04/23/2017] [Accepted: 05/11/2017] [Indexed: 12/23/2022]
Abstract
AIMS Activation of the NAD+ dependent protein deacetylase SIRT1 has been proposed as a therapeutic strategy to treat mitochondrial dysfunction and insulin resistance in skeletal muscle. However, lifelong overexpression of SIRT1 in skeletal muscle does not improve parameters of mitochondrial function and insulin sensitivity. In this study, we investigated whether temporal overexpression of SIRT1 in muscle of adult mice would affect skeletal muscle mitochondrial function and insulin sensitivity. METHODS To circumvent potential effects of germline SIRT1 overexpression, we utilized an inducible model of SIRT1 overexpression in skeletal muscle of adult mice (i-mOX). Insulin sensitivity was assessed by 2-deoxyglucose uptake, muscle maximal respiratory function by high-resolution respirometry and systemic energy expenditure was assessed by whole body calorimetry. RESULTS Although SIRT1 was highly, and specifically, overexpressed in skeletal muscle of i-mOX compared to WT mice, glucose tolerance and skeletal muscle insulin sensitivity were comparable between genotypes. Additionally, markers of mitochondrial biogenesis, muscle maximal respiratory function and whole-body oxygen consumption were also unaffected by SIRT1 overexpression. CONCLUSION These results support previous work demonstrating that induction of SIRT1 in skeletal muscle, either at birth or in adulthood, does not impact muscle insulin action or mitochondrial function.
Collapse
Affiliation(s)
- K. Svensson
- Department of Orthopaedic Surgery; University of California San Diego; La Jolla CA USA
| | - S. A. LaBarge
- Department of Orthopaedic Surgery; University of California San Diego; La Jolla CA USA
| | - V. F. Martins
- Department of Orthopaedic Surgery; University of California San Diego; La Jolla CA USA
| | - S. Schenk
- Department of Orthopaedic Surgery; University of California San Diego; La Jolla CA USA
- Biomedical Sciences Graduate Program; University of California San Diego; La Jolla CA USA
| |
Collapse
|
11
|
Vazquez-Anaya G, Martinez B, Soñanez-Organis JG, Nakano D, Nishiyama A, Ortiz RM. Exogenous thyroxine improves glucose intolerance in insulin-resistant rats. J Endocrinol 2017; 232:501-511. [PMID: 27980001 PMCID: PMC5419047 DOI: 10.1530/joe-16-0428] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Accepted: 12/15/2016] [Indexed: 12/19/2022]
Abstract
Both hypothyroidism and hyperthyroidism are associated with glucose intolerance, calling into question the contribution of thyroid hormones (TH) on glucose regulation. TH analogues and derivatives may be effective treatment options for glucose intolerance and insulin resistance (IR), but their potential glucoregulatory effects during conditions of impaired metabolism are not well described. To assess the effects of thyroxine (T4) on glucose intolerance in a model of insulin resistance, an oral glucose tolerance test (oGTT) was performed on three groups of rats (n = 8): (1) lean, Long Evans Tokushima Otsuka (LETO), (2) obese, Otsuka Long Evans Tokushima Fatty (OLETF) and (3) OLETF + T4 (8.0 µg/100 g BM/day × 5 weeks). T4 attenuated glucose intolerance by 15% and decreased IR index (IRI) by 34% in T4-treated OLETF compared to untreated OLETF despite a 31% decrease in muscle Glut4 mRNA expression. T4 increased the mRNA expressions of muscle monocarboxylate transporter 10 (Mct10), deiodinase type 2 (Di2), sirtuin 1 (Sirt1) and uncoupling protein 2 (Ucp2) by 1.8-, 2.2-, 2.7- and 1.4-fold, respectively, compared to OLETF. Activation of AMP-activated protein kinase (AMPK) and insulin receptor were not significantly altered suggesting that the improvements in glucose intolerance and IR were independent of enhanced insulin-mediated signaling. The results suggest that T4 treatment increased the influx of T4 in skeletal muscle and, with an increase of DI2, increased the availability of the biologically active T3 to upregulate key factors such SIRT1 and UCP2 involved in cellular metabolism and glucose homeostasis.
Collapse
Affiliation(s)
| | - Bridget Martinez
- Department of Molecular & Cellular BiologyUniversity of California, Merced, California, USA
| | - José G Soñanez-Organis
- Division of Science and EngineeringDepartment of Chemical Biological and Agropecuary Sciences, University of Sonora, Navojoa, Sonora, Mexico
| | - Daisuke Nakano
- Department of PharmacologyFaculty of Medicine, Kagawa University, Kagawa, Japan
| | - Akira Nishiyama
- Department of PharmacologyFaculty of Medicine, Kagawa University, Kagawa, Japan
| | - Rudy M Ortiz
- Department of Molecular & Cellular BiologyUniversity of California, Merced, California, USA
| |
Collapse
|
12
|
Uddin GM, Youngson NA, Sinclair DA, Morris MJ. Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice. Front Pharmacol 2016; 7:258. [PMID: 27594836 PMCID: PMC4990541 DOI: 10.3389/fphar.2016.00258] [Citation(s) in RCA: 67] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2016] [Accepted: 08/02/2016] [Indexed: 12/17/2022] Open
Abstract
Obesity is well known to be a major cause of several chronic metabolic diseases, which can be partially counteracted by exercise. This is due, in part, to an upregulation of mitochondrial activity through increased nicotinamide adenine dinucleotide (NAD+). Recent studies have shown that NAD+ levels can be increased by using the NAD+ precursor, nicotinamide mononucleotide (NMN) leading to the suggestion that NMN could be a useful intervention in diet related metabolic disorders. In this study we compared the metabolic, and especially mitochondrial-associated, effects of exercise and NMN in ameliorating the consequences of high-fat diet (HFD) induced obesity in mice. Sixty female 5 week old C57BL6/J mice were allocated across five groups: Chow sedentary: CS; Chow exercise: CEX; HFD sedentary: HS; HFD NMN: HNMN; HFD exercise: HEX (12/group). After 6 weeks of diet, exercise groups underwent treadmill exercise (15 m/min for 45 min), 6 days per week for 6 weeks. NMN or vehicle (500 mg/kg body weight) was injected (i.p.) daily for the last 17 days. No significant alteration in body weight was observed in response to exercise or NMN. The HFD significantly altered adiposity, glucose tolerance, plasma insulin, NADH levels and citrate synthase activity in muscle and liver. HEX and HNMN groups both showed significantly improved glucose tolerance compared to the HS group. NAD+ levels were increased significantly both in muscle and liver by NMN whereas exercise increased NAD+ only in muscle. Both NMN and exercise ameliorated the HFD-induced reduction in liver citrate synthase activity. However, exercise, but not NMN, ameliorated citrate synthase activity in muscle. Overall these data suggest that while exercise and NMN-supplementation can induce similar reversal of the glucose intolerance induced by obesity, they are associated with tissue-specific effects and differential alterations to mitochondrial function in muscle and liver.
Collapse
Affiliation(s)
- Golam M Uddin
- Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, NSW Australia
| | - Neil A Youngson
- Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, NSW Australia
| | - David A Sinclair
- Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, NSWAustralia; Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MAUSA
| | - Margaret J Morris
- Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, NSW Australia
| |
Collapse
|
13
|
Brandon AE, Stuart E, Leslie SJ, Hoehn KL, James DE, Kraegen EW, Turner N, Cooney GJ. Minimal impact of age and housing temperature on the metabolic phenotype of Acc2-/- mice. J Endocrinol 2016; 228:127-34. [PMID: 26668208 PMCID: PMC4906541 DOI: 10.1530/joe-15-0444] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/14/2015] [Indexed: 12/13/2022]
Abstract
An important regulator of fatty acid oxidation (FAO) is the allosteric inhibition of CPT-1 by malonyl-CoA produced by the enzyme acetyl-CoA carboxylase 2 (ACC2). Initial studies suggested that deletion of Acc2 (Acacb) increased fat oxidation and reduced adipose tissue mass but in an independently generated strain of Acc2 knockout mice we observed increased whole-body and skeletal muscle FAO and a compensatory increase in muscle glycogen stores without changes in glucose tolerance, energy expenditure or fat mass in young mice (12-16 weeks). The aim of the present study was to determine whether there was any effect of age or housing at thermoneutrality (29 °C; which reduces total energy expenditure) on the phenotype of Acc2 knockout mice. At 42-54 weeks of age, male WT and Acc2(-/-) mice had similar body weight, fat mass, muscle triglyceride content and glucose tolerance. Consistent with younger Acc2(-/-) mice, aged Acc2(-/-) mice showed increased whole-body FAO (24 h average respiratory exchange ratio=0.95±0.02 and 0.92±0.02 for WT and Acc2(-/-) mice respectively, P<0.05) and skeletal muscle glycogen content (+60%, P<0.05) without any detectable change in whole-body energy expenditure. Hyperinsulinaemic-euglycaemic clamp studies revealed no difference in insulin action between groups with similar glucose infusion rates and tissue glucose uptake. Housing Acc2(-/-) mice at 29 °C did not alter body composition, glucose tolerance or the effects of fat feeding compared with WT mice. These results confirm that manipulation of Acc2 may alter FAO in mice, but this has little impact on body composition or insulin action.
Collapse
Affiliation(s)
- Amanda E Brandon
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Ella Stuart
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Simon J Leslie
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Kyle L Hoehn
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - David E James
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Edward W Kraegen
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Nigel Turner
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| | - Gregory J Cooney
- Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia Diabetes and Metabolism DivisionGarvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, AustraliaSt Vincent's Clinical SchoolUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Medical SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Biotechnology and Biomolecular SciencesUniversity of New South Wales Australia, Sydney, New South Wales, AustraliaSchool of Molecular Bioscience and Sydney Medical SchoolCharles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
14
|
SIRT1 Gain of Function Does Not Mimic or Enhance the Adaptations to Intermittent Fasting. Cell Rep 2016; 14:2068-2075. [PMID: 26923584 DOI: 10.1016/j.celrep.2016.02.007] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2015] [Revised: 11/03/2015] [Accepted: 01/26/2016] [Indexed: 02/04/2023] Open
Abstract
Caloric restriction (CR) has been shown to prevent the onset of insulin resistance and to delay age-related physiological decline in mammalian organisms. SIRT1, a NAD(+)-dependent deacetylase enzyme, has been suggested to mediate the adaptive responses to CR, leading to the speculation that SIRT1 activation could be therapeutically used as a CR-mimetic strategy. Here, we used a mouse model of moderate SIRT1 overexpression to test whether SIRT1 gain of function could mimic or boost the metabolic benefits induced by every-other-day feeding (EODF). Our results indicate that SIRT1 transgenesis does not affect the ability of EODF to decrease adiposity and improve insulin sensitivity. Transcriptomic analyses revealed that SIRT1 transgenesis and EODF promote very distinct adaptations in individual tissues, some of which can be even be metabolically opposite, as in brown adipose tissue. Therefore, whereas SIRT1 overexpression and CR both improve glucose metabolism and insulin sensitivity, the etiologies of these benefits are largely different.
Collapse
|
15
|
Fang M, Fan Z, Tian W, Zhao Y, Li P, Xu H, Zhou B, Zhang L, Wu X, Xu Y. HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS 2015; 1859:294-305. [PMID: 26619800 DOI: 10.1016/j.bbagrm.2015.11.010] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2015] [Revised: 11/13/2015] [Accepted: 11/23/2015] [Indexed: 01/08/2023]
Abstract
Metabolic homeostasis is achieved through balanced energy storage and output. Impairment of energy expenditure is a hallmark event in patients with obesity and type 2 diabetes. Previously we have shown that the pro-inflammatory cytokine interferon gamma (IFN-γ) disrupts energy expenditure in skeletal muscle cells via hypermethylated in cancer 1 (HIC1)-class II transactivator (CIITA) dependent repression of SIRT1 transcription. Here we report that repression of SIRT1 transcription by IFN-γ paralleled loss of histone acetylation on the SIRT1 promoter region with simultaneous recruitment of histone deacetylase 4 (HDAC4). IFN-γ activated HDAC4 in vitro and in vivo by up-regulating its expression and stimulating its nuclear accumulation. HIC1 and CIITA recruited HDAC4 to the SIRT1 promoter and cooperated with HDAC4 to repress SIRT1 transcription. HDAC4 depletion by small interfering RNA or pharmaceutical inhibition normalized histone acetylation on the SIRT1 promoter and restored SIRT1 expression in the presence of IFN-γ. Over-expression of HDAC4 suppressed the transcription of genes involved in energy expenditure in a SIRT1-dependent manner. In contrast, HDAC4 knockdown/inhibition neutralized the effect of IFN-γ on cellular metabolism by normalizing SIRT1 expression. Therefore, our data reveal a role for HDAC4 in regulating cellular energy output and as such provide insights into rationalized design of novel anti-diabetic therapeutics.
Collapse
Affiliation(s)
- Mingming Fang
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China; Department of Nursing, Jiangsu Jiankang Vocational University, Nanjing, China
| | - Zhiwen Fan
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Wenfang Tian
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Yuhao Zhao
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Ping Li
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Huihui Xu
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Bisheng Zhou
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China
| | - Liping Zhang
- Department of Biochemistry, Xinjiang Medical University, Urumqi, China
| | - Xiaoyan Wu
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
| | - Yong Xu
- Key Laboratory of Cardiovascular Disease, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
| |
Collapse
|
16
|
Du YP, Song GY, Wang FJ, Ren LP, Liu YQ, Zhang YN, Qi HQ, Ding HX. Effect of oxymatrine on insulin resistance in patients with type 2 diabetes mellitus. Shijie Huaren Xiaohua Zazhi 2015; 23:2555-2561. [DOI: 10.11569/wcjd.v23.i16.2555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To observe the influence of oxymatrine on insulin resistance in patients with type 2 diabetes mellitus and the mechanism involved.
METHODS: This was a prospective randomized controlled clinical study. Patients with type 2 diabetes mellitus were divided into either an oxymatrine treatment group or an untreated group. Glucose oxidase method was used to detect serum fasting blood glucose (FBG) and fasting insulin (FINS). The homeostasis model assessment of insulin resistance (HOMA-IR) and homeostasis model assessment of insulin sensitivity index (HOMA-ISI) were also detected. ELISA was carried out to detect the serum levels of reactive oxygen species (ROS) and tumor necrosis factor-α (TNF-α). Western blot was used to detect the expression of protein kinase B (AKT), p-AKT, glycogen synthase kinase-3α/β (GSK3α/β), and p-GSK3α/β proteins.
RESULTS: FBG, FINS and HOMA-IR significantly decreased and HOMA-ISI increased in the oxymatrine treatment group compared with the untreated group (P < 0.05). Serum levels of ROS and TNF-α in the oxymatrine treatment group decreased significantly compared with the untreated group (P < 0.05). Western blot analysis showed that the total protein levels of AKT and GSK3α/β were unchanged (P > 0.05), but the expression of p-AKT and p-GSK3α/β significantly increased in the oxymatrine treatment group compared with the untreated group (P < 0.05).
CONCLUSION: Oxymatrine can reduce FBG and FINS, and improve insulin resistance by reducing the production of serum ROS and TNF-α and by influencing the photophosphorylation of key proteins (such as AKT and GSK3α/β) in the insulin resistance-related signaling pathways.
Collapse
|